Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on November 11, 2026

4 hours ago

aTyr Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

America’s VetDogs and Veteran Pathways of New England Announce Partnership to Connect Veterans with Life-Changing Service Dogs

Indeterminate GlobeNewswire

4 hours ago

ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

4 hours ago

Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026

Indeterminate GlobeNewswire

4 hours ago

Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London

Indeterminate GlobeNewswire

4 hours ago

 BioAge Labs to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board

Indeterminate GlobeNewswire

4 hours ago

Boston Concierge Orthopedics Launches New Website Highlighting Shoulder and Knee Care

Indeterminate GlobeNewswire

4 hours ago

Arcadia Honors Healthcare Leaders Driving Measurable Impact

Indeterminate GlobeNewswire

5 hours ago

Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030

Indeterminate GlobeNewswire

5 hours ago

PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

5 hours ago

Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

5 hours ago

BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026

Indeterminate GlobeNewswire

5 hours ago

Dyne Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

5 hours ago

MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Commercial Product Revenue from agenT-797, Randomized ARDS Trial Advancing, and ARPA-H Selection for Deployable Cell Therapies

Indeterminate GlobeNewswire

5 hours ago

Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering

Indeterminate GlobeNewswire

5 hours ago

AC Immune to Present at Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire

5 hours ago

Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease

Indeterminate GlobeNewswire

5 hours ago

CHARM Therapeutics and Collaborator Dr. Florian Perner to Present Compelling Data Showing the Potential of Next-Generation Menin Inhibitors to Deliver More Durable Responses for AML at the 8th ASH Annual Meeting

Indeterminate GlobeNewswire

5 hours ago

Arvinas to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire